Ad www.AngelOne.in
FREE Account Opening + Zero AMC Fees* + MutualFund SIP1
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Ad www.AngelOne.in
Right Issue Status: Closed [26th Feb 2024 to 15th Mar 2024]
Dipna Pharmachem offers a Right Issue size of Rs 12.97 Cr. which subscription is opening from26 Feb to 07 Mar 2024. The company issues 13 right equity shares for every 12 fully paid-up equity shares held on the record date, 6 Feb 2025. The face value of a share is Rs 10 per share and the right issue price is fixed at Rs. 10 per share.
Stay updated with us to know more about the Dipna Pharmachem IPO Details 2024 including issue size, right issue entitlement, terms of payment, and more.
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
| Dipna Pharmachem Issue Details | Values |
|---|---|
| Category | RightIssue |
| Right Issue Issue Size (Shares) | 1.30 Cr Shares |
| Right Issue Issue Size (Amount) | ₹12.97 Cr |
| Face Value | ₹10 Per Equity Share |
| Right Issue - Issue Price | ₹10 per share |
| Right Issue Record Date | 12th Feb 2024 |
| Right Issue Entitlement | 13 Rights Equity Share(s) for every 12 fully paid-up Equity Shares held on Record Date |
| Right Issue Terms of payment | |
| Listing At | BSE |
| BSE Code | 543594 |
| NSE Code |
In this section we have covered all important dates related to Dipna Pharmachem Right Issue. Dates are updated as they are announced. The most noted dates are Right Issue start date and Right Issue end date, which one should use to participate in Right Issue.
| Right Issue Activity | Date |
|---|---|
| Right Issue Issue Open Date | 26th Feb 2024 |
| Right Issue Issue Close Date | 15th Mar 2024 |
| Basis of Allotment Finalisation Date* | 14th Mar 2024 |
| Refunds Initiation* | 4th Mar 2024 |
| Credit of Shares to Demat Account* | 15th Mar 2024 |
| Right Issue Listing Date* | 18th Mar 2024 |
* - Tentative Dates
Zerodha Trade@20
Dipna Pharmachem Limited is a trader, importer, and exporter of Industrial chemical and pharmaceutical raw materials.
Its product portfolio includes industrial chemical and pharmaceutical raw materials, solvents, APIs, formulation and intermediates, and assistance in setting up contract manufacturing compliance. The company export its products throughout the world.
Past performance and financial results of Dipna Pharmachem .
Dipna Pharmachem Ltd.'s revenue increased by 37.34% and profit after tax (PAT) dropped by -21.85% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 77.56 | 36.23 |
| Revenue | 99.93 | 72.77 |
| Profit After Tax | 0.91 | 1.17 |
| Reserves and Surplus | 12.39 | 1.70 |
| Amount in ₹ Crore | ||
The table below is live update of Right Issue bidding details from NSE and BSE.
Dipna Pharmachem Right Issue Offer Document (Letter of Offer) >>Document
Dipna Pharmachem Right Issue Offer Document (Letter of Offer) >>Dipna Pharmachem Right Issue Red Herring Prospectus is not yet available.
Dipna Pharmachem Right Issue Online Application (Registrar & Transfer Agent) >>Online Application
Dipna Pharmachem Right Issue Online Application (Registrar & Transfer Agent) >>Dipna Pharmachem Right Issue RTA information is not yet available.
Last Updated on 2024-03-18T05:33:06+00:00
